Accessibility Menu
 
GlucoTrack logo

GlucoTrack

(NASDAQ) GCTK

Current Price$1.09
Market Cap$1.11M
Since IPO (2013)-100%
5 Year-100%
1 Year-96%
1 Month-33%

GlucoTrack Financials at a Glance

Market Cap

$1.11M

Revenue (TTM)

$0.00

Net Income (TTM)

$25.85M

EPS (TTM)

$-1359.65

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.75 (Low)

Price

$1.09

Volume

63,906

Open

$1.10

Previous Close

$1.09

Daily Range

$1.04 - $1.10

52-Week Range

$1.04 - $29.40

GCTK News

No articles available.

GCTK: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About GlucoTrack

Industry

Healthcare Equipment and Supplies

Employees

11

CEO

Paul V. Goode, PhD

Headquarters

Or Yehuda, 7760049, IL

GCTK Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-1491%

Return on Capital

-5%

Return on Assets

-3%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.11M

Shares Outstanding

1.01M

Volume

63.91K

Short Interest

0.00%

Avg. Volume

343.83K

Financials (TTM)

Gross Profit

$36.00K

Operating Income

$14.55M

EBITDA

$21.98M

Operating Cash Flow

$12.49M

Capital Expenditure

$104.00K

Free Cash Flow

$12.59M

Cash & ST Invst.

$5.62M

Total Debt

$267.00K

GlucoTrack Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$9.00K

+10.0%

Gross Margin

0.00%

N/A

Market Cap

$1.11M

N/A

Market Cap/Employee

$100.67K

N/A

Employees

11

N/A

Net Income

$4.17M

+18.0%

EBITDA

$4.16M

-28.9%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$7.83M

+510.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$12.00K

-94.9%

Short Term Debt

$28.00K

-98.6%

Return on Assets

-3.12%

N/A

Return on Invested Capital

-5.50%

N/A

Free Cash Flow

$4.69M

-12.3%

Operating Cash Flow

$4.62M

-11.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INMInMed Pharmaceuticals Inc.
$0.82-0.29%
NAOVNanoVibronix, Inc.
$1.90+1.06%
VEROVenus Concept Inc.
$0.31-0.90%
BGMSBio Green Med Solution, Inc.
$0.94+2.17%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%
CSCOCisco Systems
$77.65-0.01%

Questions About GCTK

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.